Further studies are necessary such as gene silencing for SHP-2 or mcl-1L to verify the precise mechanisms responsible for the different regulation between tanshinone IIA and cryptotanshinone against CML cells in the near future. The gene discussed is PTPN11; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.